Andere talen Lineage Cell Therapeutics, Inc.

Aandelen

LCTX

US53566P1093

Beurs gesloten - Nyse Andere beurzen 22:00:00 09-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,18 ^USD	+1,72%		+12,38%	+8,26%

06/05	Lineage Cell Therapeutics, Inc. Kondigt 24 maanden gezichtsscherpte resultaten aan die worden besproken op 2024 Retinal Cell & Gene Therapy Innovation Summit	CI
29/04	Lineage Cell Therapeutics, Inc. Kondigt wijzigingen aan in de Raad van Bestuur	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Lineage Cell: Q1 Earnings Snapshot	09/05
Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M	09/05
Lineage Cell Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Update	09/05
LINEAGE CELL - OPREGEN PHASE 1/2A CLINICAL STUDY 24-MONTH VISUAL ACUITY RESULTS FEATURED AT 2024 RETINAL CELL AND GENE THERAPY INNOVATION SUMMIT	07/05
OpRegen® (RG6501) Phase 1/2a Clinical Study 24-Month Visual Acuity Results Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit	06/05
Lineage Cell Therapeutics, Inc. Announces 24 Month Visual Acuity Results Featured At 2024 Retinal Cell & Gene Therapy Innovation Summit	06/05
Lineage Cell Therapeutics to Report First Quarter 2024 Financial Results and Provide Business Update on May 9, 2024	02/05
LINEAGE RECEIVES GRANT FROM CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE	01/05
Lineage Cell Therapeutics : Immediate Report	30/04
Lineage Cell Therapeutics : Additional proxy soliciting materials - definitive	30/04
Lineage Cell Therapeutics : NOTICE OF ANNUAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 11, 2024, PROXY	30/04
Lineage Receives Grant From California Institute for Regenerative Medicine (CIRM)	30/04
Lineage Announces Changes to Board of Directors	29/04
Lineage Cell Therapeutics, Inc. Announces Changes to Board of Directors	29/04
Lineage Announces Appointment of Charlotte Hubbert, Ph.D., as Vice President of Corporate Development	01/04
Lineage Cell Therapeutics : Immediate Report	24/03
Lineage Cell Therapeutics and the Christopher & Dana Reeve Foundation Proudly Announce the 2nd Annual Spinal Cord Injury Investor Symposium	18/03
LINEAGE CELL THERAPEUTICS, INC. - RG6501 PHASE 1/2A CLINICAL STUDY 24 MONTH RESULTS TO BE FEATURED AT 2024 RETINAL CELL AND GENE THERAPY INNOVATION SUMMIT	14/03
RG6501 (OpRegen®) Phase 1/2a Clinical Study 24 Month Results to Be Featured at 2024 Retinal Cell & Gene Therapy Innovation Summit	13/03
RG6501 (OpRegen®) Preclinical Engraftment Results to Be Presented at 2024 Association for Research in Vision and Ophthalmology Meeting	11/03

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Lineage Cell Therapeutics, Inc.

Aandelen

LCTX

US53566P1093

Andere talen

Filters